Bacteremia by Chryseobacterium oranimense, A Colistin-Resistant Gram-Negative Bacilli, in an Immunocompetent Pediatric Patient

Pediatr Infect Dis J. 2019 Feb;38(2):217-218. doi: 10.1097/INF.0000000000002236.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology*
  • Autistic Disorder / complications
  • Bacteremia / diagnosis*
  • Bacteremia / microbiology
  • Bacteremia / pathology
  • Child
  • Chryseobacterium / drug effects
  • Chryseobacterium / isolation & purification*
  • Ciprofloxacin / administration & dosage
  • Colistin / pharmacology*
  • Drug Resistance, Bacterial*
  • Female
  • Gram-Negative Bacterial Infections / diagnosis*
  • Gram-Negative Bacterial Infections / microbiology
  • Gram-Negative Bacterial Infections / pathology
  • Humans
  • Treatment Outcome
  • Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Colistin

Supplementary concepts

  • Chryseobacterium oranimense